Evidence map›Paper›PMID 37861852›Full record

ReviewCurrent cardiology reports2023

Contraception and Cardiovascular Effects: What Should the Cardiologist Know?

Anhthu Trinh, Ankit Vyas, Anna Roselle, Dhivya Velu, Lekha Hota, Madhavi Kadiyala

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anhthu Trinh *West Virginia University School of Medicine, Morgantown, WV, USA.
Ankit Vyas *Department of Internal Medicine, Baptist Hospitals of Southeast Texas Beaumont, Beaumont, TX, USA.
Anna RoselleHarvard Medical School, Boston, MA, USA.
Dhivya VeluDepartment of Internal Medicine, Baptist Hospitals of Southeast Texas Beaumont, Beaumont, TX, USA.
Lekha HotaDepartment of Obstetrics & Gynecology, Division of Urogynecology, Ochsner Medical Center, New Orleans, LA, USA.
Madhavi KadiyalaDivision of Cardiology/Cardiovascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA, 02111, USA. Madhavi.kadiyala@tuftsmedicine.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewCardiovascular disease (CVD) is the leading cause of death in women. This review highlights contraceptive options and their effects on the cardiovascular system (CVS). It provides guidance to cardiologists to make informed decisions regarding the safety of contraceptive use and cardiovascular risk stratification in the care of women of childbearing age. RECENT

findingsApproximately 44% of American women live with some type of CVD. Many women use hormonal contraception during their lifetime. It is imperative that cardiologists have a robust understanding of the forms of contraception in current use and their cardiovascular effects. This contemporary review provides a comprehensive summary of available contraceptive methods to practicing cardiologists and aims to be used as a resource to guide cardiovascular specialists on contraception in the context of cardiovascular disease.

Indexed as

CardiologistsCardiovascular DiseasesCardiovascular SystemContraceptionContraceptive AgentsFemaleHumansUnited StatesContraceptive AgentsAdults with congenital heart disease (ACHD)Cardiovascular disease (CVD)Coronary heart diseaseOral contraceptivesPregnancy

Identifiers

PMID37861852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.